STOCK TITAN

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Penumbra (NYSE: PEN) has scheduled its fourth quarter and full year 2024 earnings release and conference call for February 18, 2025. The company will issue a press release detailing financial results after market close, followed by a conference call at 4:30 PM Eastern Time.

Investors can access the conference call by dialing (888) 596-4144 with conference ID 5872954, or join via webcast through the 'Events and Presentations' section on Penumbra's website. The webcast recording will remain available for at least two weeks after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+2.85% News Effect

On the day this news was published, PEN gained 2.85%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALAMEDA, Calif., Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18, 2025 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2024 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-fourth-quarter-and-full-year-2024-earnings-release-and-conference-call-for-february-18-2025-302356557.html

SOURCE Penumbra, Inc.

FAQ

When will Penumbra (PEN) release its Q4 and full year 2024 earnings?

Penumbra will release its Q4 and full year 2024 earnings after market close on Tuesday, February 18, 2025.

How can investors join Penumbra's (PEN) Q4 2024 earnings call?

Investors can join by dialing (888) 596-4144 (conference ID: 5872954) or accessing the webcast through the 'Events and Presentations' section on Penumbra's website.

What time is Penumbra's (PEN) Q4 2024 earnings conference call?

Penumbra's Q4 2024 earnings conference call is scheduled for 4:30 PM Eastern Time on February 18, 2025.

How long will Penumbra's (PEN) Q4 2024 earnings webcast be available?

The webcast will be available on Penumbra's website for at least two weeks following the completion of the call.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

12.36B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA